Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Leukemia & Lymphoma|September 30, 2014
Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidineVu H Duong, Bhavana Bhatnagar, Dan P Zandberg, et al.Journal of Adolescent and Young Adult Oncology|July 25, 2020
Palliative Care Referral Patterns for Adolescent and Young Adult Patients at a Comprehensive Cancer CenterBethany J Lockwood, Olanipekun L Ntukidem, Sarah E Ehrman, et al.Annals of Hematology|October 8, 2013
Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignanciesBhavana Bhatnagar, Aaron P Rapoport, Hong-Bin Fang, et al.Leukemia & Lymphoma|October 23, 2013
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapyBhavana Bhatnagar, Vu H Duong, Theodore S Gourdin, et al.Journal of Hematology & Oncology|August 3, 2022
Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agentsSangmin Lee, Sanjay Mohan, Jessica Knupp, et al.Cancers|January 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation TrialShivani Handa, Kristin Koenig, Qiuhong Zhao, et al.Blood Advances|July 7, 2022
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factorsDaelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, et al.Leukemia & Lymphoma|January 20, 2016
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemiaAlison R Walker, Hongyan Wang, Katherine Walsh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the NucleusParvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, et al.Leukemia & Lymphoma|February 11, 2020
Phase I study of AR-42 and decitabine in acute myeloid leukemiaSophia G Liva, Christopher C Coss, Jiang Wang, et al.Pageof 6